Carey‐Ann D. Burnham
- Clinical Biochemistry top 0.05%
- Bacterial Identification and Susceptibility Testing 114
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 54
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 71
- Clostridium difficile and Clostridium perfringens research 60
- Endocrinology top 0.5%
-
- Streptococcal Infections and Treatments 30
-
- Urinary Tract Infections Management 23
-
- Gut microbiota and health 23
- Bacterial biofilms and quorum sensing 22
Carey‐Ann D. Burnham
294 papers receiving 8.4k citations
Peers
Comparison fields: 5 of 170
- Clinical Biochemistry 2.3k
- Molecular Medicine 1.4k
- Applied Microbiology and Biotechnology 438
- Infectious Diseases 3.4k
- Endocrinology 790
Countries citing papers authored by Carey‐Ann D. Burnham
This map shows the geographic impact of Carey‐Ann D. Burnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carey‐Ann D. Burnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carey‐Ann D. Burnham more than expected).
Fields of papers citing papers by Carey‐Ann D. Burnham
This network shows the impact of papers produced by Carey‐Ann D. Burnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carey‐Ann D. Burnham. The network helps show where Carey‐Ann D. Burnham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carey‐Ann D. Burnham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 27 | |
| 8 | 2021 | 24 | |
| 9 | 2020 | 48 | |
| 10 | 2020 | 1 | |
| 11 | 2019 | 80 | |
| 12 | 2018 | 9 | |
| 13 | 2018 | 62 | |
| 14 | 2017 | 41 | |
| 15 | 2017 | 3 | |
| 16 | 2017 | 8 | |
| 17 | 2016 | 13 | |
| 18 | 2016 | 12 | |
| 19 | 2015 | 14 | |
| 20 | 2015 | 55 |
About Carey‐Ann D. Burnham
Carey‐Ann D. Burnham is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases, having authored 300 papers that have together received 8.6k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (114 papers), Antimicrobial Resistance in Staphylococcus (71 papers), Clostridium difficile and Clostridium perfringens research (60 papers), Antibiotic Resistance in Bacteria (54 papers), Streptococcal Infections and Treatments (30 papers), Urinary Tract Infections Management (23 papers), Gut microbiota and health (23 papers) and Bacterial biofilms and quorum sensing (22 papers). The work is most often cited by research in Clinical Biochemistry (2.3k citations), Molecular Medicine (1.4k citations) and Applied Microbiology and Biotechnology (438 citations). Carey‐Ann D. Burnham has collaborated with scholars based in United States, Canada and Pakistan. Frequent co-authors include Meghan A. Wallace, Gautam Dantas, Karen C. Carroll, Erik R. Dubberke, Tiffany Hink, Christopher D. Doern, Jennie H. Kwon, Erin McElvania, Stephanie A. Fritz and Melanie L. Yarbrough.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.